News

Keep up to date on our latest product launches, news, and conference appearances.

January 28, 2021News, News Announcements

HLA class II typed cells to accelerate effective research on immunotherapies

We support effective research on immunotherapies by expanding the range of HLA-types provided for all Human Primary Cells and Blood & Stem Cells. In addition to the MHC class I genes HLA-A, -B, and -C, we now also offer 4-digit resolution for MHC class II genes HLA-DPA1/DPB1, -DQA1/DQB1, and -DRB1/DRB345.
The Human Leukocyte Antigen (HLA) system plays a fundamental role in the determination of histocompatibility between different individuals and regulation of the human immunity….

Full Article
January 18, 2021News, News Announcements

PromoCell is now EXCiPACT™ GMP certified

We have successfully completed a comprehensive EXCiPACT™ audit that certifies PromoCell as a manufacturer of pharmaceutical excipients to Good Manufacturing Practice (GMP) standards. This means we can now provide tailor-made cell culture media and reagents based on your regulatory requirements….

Full Article
3D Illustration of Immune System cells attacking a HIV Virus
November 26, 2020News, News Announcements

New Research Tools to Develop Drugs against HIV

Although the COVID-19 pandemic has engulfed public consciousness, acquired immunodeficiency syndrome (AIDS) still represents a serious global threat.
Human immunodeficiency virus (HIV) causes AIDS and is one of the most infectious diseases, with millions of people infected each year and a high mortality rate. Thus, great effort is still being invested in understanding HIV and the >$30.5 billion HIV drug market continues to grow….

Full Article